Join KCAS Bio at Applied Pharmaceutical Analysis (APA) 2025, taking place October 6-8 in Cambridge, Massachusetts. This scientific meeting, hosted by The Boston Society features three days of expert-led workshops on Regulated Bioanalysis, Discovery Bioanalysis, and Mechanistic ADME. The Mechanistic ADME track explores innovative topics such as PROTACs, molecular glues, hepatotoxicity mechanisms, and AI/ML-driven early dose prediction in drug development.
The program offers a unique platform to engage with fellow scientists on current challenges and forward-looking strategies in bioanalysis. This event fosters dialogue across small and large molecule analysis, supporting advancement in biologics and beyond.
See program details here.
Driving Innovation in Biologics at KCAS Bio
KCAS Bio brings deep scientific insight and technical precision to every stage of drug development, supporting partners with comprehensive bioanalytical and ADME solutions. From regulated bioanalysis to mechanistic modeling, our team helps uncover the data needed to move therapies forward with clarity and confidence. With expertise spanning small molecules, biologics, and novel modalities, KCAS Bio empowers decision-making through customized, science-driven strategies that align with the evolving demands of modern drug development.
Our participation in APA demonstrates our commitment to scientific dialogue and collaboration that moves the industry forward.
Let’s Connect at APA 2025
Connect with KCAS Bio throughout the Applied Pharmaceutical Analysis conference.
Our team will be on hand to engage in thoughtful conversations around bioanalysis, mechanistic ADME, and all phases of drug development. Whether you’re exploring early discovery or navigating regulated study requirements, we’re ready to discuss how our scientific expertise and tailored services can support your goals.